![Channing Der, PhD, is a UNC Lineberger member and a Kenan Distinguished Professor in the Department of Pharmacology at the UNC School of Medicine.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/promising-direction-image2-600x400.jpeg)
January 7, 2016
Promising treatment direction revealed for pancreatic cancers driven by KRAS mutation
In the journal Cancer Cell, UNC Lineberger researchers report findings of a promising strategy to treat KRAS-mutant pancreatic cancers.
January 7, 2016
In the journal Cancer Cell, UNC Lineberger researchers report findings of a promising strategy to treat KRAS-mutant pancreatic cancers.
September 7, 2015
A UNC Lineberger-led study, published today in Nature Genetics, paves the way for potential personalized medicine approaches for the deadly cancer type.
July 20, 2015
UNC Lineberger Comprehensive Cancer Center member Channing Der, PhD, is among four accomplished cancer researchers to join the Pancreatic Cancer Action Network’s prestigious board.
April 22, 2015
The Pancreatic Cancer Action Network and the American Association for Cancer Research announced April 16 that UNC Lineberger's Channing Der, PhD, and two co-principal investigators were chosen to receive a $1 million grant for pancreatic cancer research. Earlier this year, Der was also announced as the recipient of a grant from The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research.
April 22, 2015
UNC Lineberger's Jen Jen Yeh, MD, has been elected to the American Society for Clinical Investigation, an honor society for physician-researchers. A formal induction ceremony was held April 24 at the joint ASCI/AAP meeting in Chicago.
February 4, 2015
Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients.
August 25, 2014
Kirsten Bryant, PhD, was recently recognized by the Pancreatic Cancer Action Network for her dual role in the fight against pancreatic cancer.
May 5, 2014
UNC Lineberger will be well represented at the 2014 Pancreatic Cancer Purple Stride 5K. The event, organized by the Pancreatic Cancer Action Network, helps raise awareness and research funds for pancreatic cancer.
June 19, 2012
By Jeremy Moore
May 7, 2012
Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.